• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉血压对无细胞血红蛋白溶液的反应以及与一氧化氮的反应。

Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide.

作者信息

Rohlfs R J, Bruner E, Chiu A, Gonzales A, Gonzales M L, Magde D, Magde M D, Vandegriff K D, Winslow R M

机构信息

Department of Medicine, School of Medicine, University of California, San Diego, Veterans Affairs Medical Center, San Diego, California 92161, USA.

出版信息

J Biol Chem. 1998 May 15;273(20):12128-34. doi: 10.1074/jbc.273.20.12128.

DOI:10.1074/jbc.273.20.12128
PMID:9575158
Abstract

Changes in mean arterial pressure were monitored in rats following 50% isovolemic exchange transfusion with solutions of chemically modified hemoglobins. Blood pressure responses fall into three categories: 1) an immediate and sustained increase, 2) an immediate yet transient increase, or 3) no significant change either during or subsequent to exchange transfusion. The reactivities of these hemoglobins with nitric monoxide (.NO) were measured to test the hypothesis that different blood pressure responses to these solutions result from differences in .NO scavenging reactions. All hemoglobins studied exhibited a value of 30 microM-1 s-1 for both .NO bimolecular association rate constants and the rate constants for .NO-induced oxidation in vitro. Only the .NO dissociation rate constants and, thus, the equilibrium dissociation constants varied. Values of equilibrium dissociation constants ranged from 2 to 14 pM and varied inversely with vasopressor response. Hemoglobin solutions that exhibited either transient or no significant increase in blood pressure showed tighter .NO binding affinities than hemoglobin solutions that exhibited sustained increases. These results suggest that blood pressure increases observed upon exchange transfusion with cell-free hemoglobin solutions can not be the result of .NO scavenging reactions at the heme, but rather must be due to alternative physiologic mechanisms.

摘要

用化学修饰血红蛋白溶液对大鼠进行50%等容交换输血后,监测其平均动脉压的变化。血压反应分为三类:1)立即且持续升高;2)立即但短暂升高;3)在交换输血期间或之后无显著变化。测量这些血红蛋白与一氧化氮(.NO)的反应性,以检验以下假设:对这些溶液的不同血压反应是由于.NO清除反应的差异所致。所有研究的血红蛋白在体外.NO双分子缔合速率常数和.NO诱导氧化的速率常数均显示为30 microM-1 s-1。只有.NO解离速率常数以及平衡解离常数有所不同。平衡解离常数的值在2至14 pM之间,且与血管升压反应呈反比。与血压持续升高的血红蛋白溶液相比,血压短暂升高或无显著升高的血红蛋白溶液表现出更强的.NO结合亲和力。这些结果表明,用无细胞血红蛋白溶液进行交换输血时观察到的血压升高并非血红素处.NO清除反应的结果,而必定是由于其他生理机制所致。

相似文献

1
Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide.动脉血压对无细胞血红蛋白溶液的反应以及与一氧化氮的反应。
J Biol Chem. 1998 May 15;273(20):12128-34. doi: 10.1074/jbc.273.20.12128.
2
Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin.与一氧化氮的反应速率决定了无细胞血红蛋白的高血压作用。
Nat Biotechnol. 1998 Jul;16(7):672-6. doi: 10.1038/nbt0798-672.
3
Effects of endogenous ascorbate on oxidation, oxygenation, and toxicokinetics of cell-free modified hemoglobin after exchange transfusion in rat and guinea pig.内源性抗坏血酸对大鼠和豚鼠换血后无细胞修饰血红蛋白的氧化、氧合及毒代动力学的影响。
J Pharmacol Exp Ther. 2007 Oct;323(1):49-60. doi: 10.1124/jpet.107.126409. Epub 2007 Jul 10.
4
Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: role of nitric oxide.
J Appl Physiol (1985). 1994 Nov;77(5):2348-54. doi: 10.1152/jappl.1994.77.5.2348.
5
Systemic hemodynamic and hepatic microvascular responses to a 33% blood volume exchange with whole blood, stroma-free hemoglobin, and oxypolyhemoglobin solutions.全身血液动力学及肝脏微血管对用全血、无基质血红蛋白溶液和氧化聚血红蛋白溶液进行33%血容量交换的反应。
Biomater Artif Cells Immobilization Biotechnol. 1993;21(4):537-51. doi: 10.3109/10731199309117656.
6
Role of nitric oxide scavenging in vascular response to cell-free hemoglobin transfusion.一氧化氮清除在无细胞血红蛋白输血血管反应中的作用。
Am J Physiol Heart Circ Physiol. 2005 Sep;289(3):H1191-201. doi: 10.1152/ajpheart.00251.2005. Epub 2005 May 13.
7
Simulation of NO and O2 transport facilitated by polymerized hemoglobin solutions in an arteriole that takes into account wall shear stress-induced NO production.考虑到壁切应力诱导的一氧化氮生成,模拟聚合物血红蛋白溶液在小动脉中促进的一氧化氮和氧气的输送。
Biophys Chem. 2012 Mar;162:45-60. doi: 10.1016/j.bpc.2011.12.006. Epub 2012 Jan 9.
8
Vasoactive properties of synthetic blood substitutes.合成血液替代品的血管活性特性。
Medicina (B Aires). 1998;58(4):403-10.
9
No scavenging and the hypertensive effect of hemoglobin-based blood substitutes.基于血红蛋白的血液替代品无清除作用及其升压效应
Free Radic Biol Med. 2004 Mar 15;36(6):685-97. doi: 10.1016/j.freeradbiomed.2003.11.030.
10
Comparison of the effects of a 50% exchange-transfusion with albumin, hetastarch, and modified hemoglobin solutions.
Shock. 2002 Jan;17(1):61-9. doi: 10.1097/00024382-200201000-00011.

引用本文的文献

1
How Nitric Oxide Hindered the Search for Hemoglobin-Based Oxygen Carriers as Human Blood Substitutes.一氧化氮如何阻碍血红蛋白基氧载体作为人血代用品的研究。
Int J Mol Sci. 2023 Oct 4;24(19):14902. doi: 10.3390/ijms241914902.
2
PEGylated carboxyhemoglobin bovine (SANGUINATE) ameliorates myocardial infarction in a rat model.聚乙二醇化牛羧基血红蛋白(SANGUINATE)可改善大鼠模型中的心肌梗死。
Artif Organs. 2018 Dec;42(12):1174-1184. doi: 10.1111/aor.13384.
3
Artificial Blood for Dogs.犬用人工血
Sci Rep. 2016 Nov 10;6:36782. doi: 10.1038/srep36782.
4
Acute kidney function and morphology following topload administration of recombinant hemoglobin solution.重组血红蛋白溶液负荷给药后的急性肾功能与形态学
Artif Cells Nanomed Biotechnol. 2017 Feb;45(1):24-30. doi: 10.1080/21691401.2016.1241795. Epub 2016 Oct 31.
5
Influence of Molecular Structure on O2-Binding Properties and Blood Circulation of Hemoglobin‒Albumin Clusters.分子结构对血红蛋白-白蛋白聚集体的O2结合特性及血液循环的影响
PLoS One. 2016 Feb 19;11(2):e0149526. doi: 10.1371/journal.pone.0149526. eCollection 2016.
6
Safety Evaluation of Hemoglobin-Albumin Cluster "HemoAct" as a Red Blood Cell Substitute.血红蛋白-白蛋白聚集体“HemoAct”作为红细胞替代物的安全性评估。
Sci Rep. 2015 Jul 29;5:12778. doi: 10.1038/srep12778.
7
Supra-plasma expanders: the future of treating blood loss and anemia without red cell transfusions?超血浆扩容剂:无需红细胞输血治疗失血和贫血的未来方向?
J Infus Nurs. 2015 May-Jun;38(3):217-22. doi: 10.1097/NAN.0000000000000103.
8
Effects of infusion of human methemoglobin solution following hydrogen sulfide poisoning.硫化氢中毒后输注人高铁血红蛋白溶液的效果。
Clin Toxicol (Phila). 2015 Feb;53(2):93-101. doi: 10.3109/15563650.2014.996570. Epub 2015 Jan 29.
9
Evaluating the capacity to generate and preserve nitric oxide bioactivity in highly purified earthworm erythrocruorin: a giant polymeric hemoglobin with potential blood substitute properties.评估高度纯化的蚯蚓血红细胞血红蛋白产生和保持一氧化氮生物活性的能力:一种具有潜在血液替代特性的巨大聚合血红蛋白。
J Biol Chem. 2015 Jan 2;290(1):99-117. doi: 10.1074/jbc.M114.583260. Epub 2014 Nov 4.
10
Hemoglobin-albumin cluster incorporating a Pt nanoparticle: artificial O2 carrier with antioxidant activities.包含铂纳米颗粒的血红蛋白-白蛋白簇:具有抗氧化活性的人工氧载体。
PLoS One. 2014 Oct 13;9(10):e110541. doi: 10.1371/journal.pone.0110541. eCollection 2014.